Condition

Immunosuppression (4)

Cardiac Allograft Vasculopathy (1)

Chronic Kidney Diseases (1)

Heart Transplant Failure and Rejection (1)

Heart Transplant Infection (1)

Liver Transplant Recipients (1)

Liver Transplantation (1)

Pediatric Heart Transplantation (1)

Post-transplant Lymphoproliferative Disorder (1)

Overall Status

Completed (3)

Active, not recruiting (1)

Phase

n/a (2)

phase 2 (1)

phase 3 (1)

Sponsor

University of Pittsburgh (2)

Boston Children's Hospital (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Novartis Pharmaceuticals (2)

Immune Tolerance Network (ITN) (1)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Stanford University (1)

United States Department of Defense (1)

Intervention

myfortic (2)

cellcept (1)

everolimus (1)

immunosuppression withdrawal (1)

mycophenolate mofetil (1)

tacrolimus (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (3)

NIH (1)

Study Type

Interventional (4)

immunosuppression

Showing NaN - NaN of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pediatric Heart Transplantation, Immunosuppression, Chronic Kidney Diseases Trial in United States (Everolimus, Tacrolimus,

Active, not recruiting

Pediatric Heart Transplantation
+6 more

Everolimus
+2 more

Birmingham, Alabama
+24 more

Sep 2, 2021

Liver Transplant Recipients, Liver Transplantation, Immunosuppression Trial in Canada, United States (Immunosuppression

Completed

Has Results

Liver Transplant Recipients
+2 more

Immunosuppression withdrawal

San Francisco, California
+11 more

Sep 23, 2019